Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qingyan Lihou Capsule is a traditional Mongolian medicinal formulation developed by the Mongolian Medicine College of Inner Mongolia University for Nationalities. It is specifically indicated for the treatment of acute pharyngitis, particularly cases characterized by lung and stomach heat syndrome according to traditional medical theory. The preparation is designed to clear heat, detoxify, and alleviate pharyngeal pain and inflammation. As of 2022, the drug was undergoing Phase III clinical evaluation in China (CTR20222973) to establish its efficacy and safety profile compared to placebo in patients with acute pharyngeal infections.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qingyan Lihou Capsule.